Exhibitors

Deltex

At Deltex Medical, we’re driven by a clear mission: to combat haemodynamic instability and help clinicians improve patient outcomes worldwide. As a global leader in advanced haemodynamic monitoring, we proudly partner anaesthetists and critical care specialists to reduce preventable complications and elevate standards of care.

Introducing TrueVue™ – Advanced Insights. Better Outcomes.

At the core of our innovation is TrueVue™, the next generation in haemodynamic monitoring, built around our enhanced Oesophageal Doppler Monitoring (ODM) technology. TrueVue™ integrates superior Doppler signal acquisition with Pulse Pressure Wave Analysis, providing comprehensive, real-time data for better informed clinical decisions.

Why TrueVue™?

Unmatched Accuracy: Real-time, beat-to-beat data on Stroke Volume, Cardiac Output, Systemic Vascular Resistance, Oxygen Delivery, and Inotropy Index.
Enhanced Patient Safety: Supports clinicians in reducing the risk of complications such as acute kidney injury, acute respiratory distress syndrome, and heart failure.
Versatility in Critical Care: Optimise preload, afterload, and contractility in complex scenarios, including sepsis, trauma, and burns.
User-Centred Design: Advanced data in an intuitive, easy-to-use format.

Join Us at APICS 2025

See TrueVue™ in action at the Asia Pacific Intensive Care Symposium (APICS), 15 – 17 August 2025, in Singapore. Our team will be on hand to demonstrate how our cutting-edge technology can improve outcomes, enhance patient safety, and reduce healthcare costs.

For more information, visit www.deltexmedical.com

Fresenius Kabi

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With more than 43,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.

Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of almost 450 million patients annually. With Vision 2026, as part of the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.

For more information, please visit www.fresenius-kabi.com/sg

GE HealthCare

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalised, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $19 billion business with 50,000 employees working to create a world where healthcare has no limits.

I:Emedics

I:Emedics Pte Ltd is a medical device distributor based in Singapore, established in 2005. With a focus on Anaesthesiology, ENT, Respiratory, and Wound Care products, we are committed to providing high-quality medical devices to the healthcare industry in Singapore.

Our mission is to make a difference in people’s lives by providing innovative medical products that improve patient outcomes. We work with leading manufacturers worldwide to bring the latest medical technology to healthcare professionals in Singapore.

At I:Emedics, we pride ourselves in our commitment to customer service. We work closely with our customers to understand their needs and provide customised solutions that meet their unique requirements. Our team of experienced professionals is dedicated to providing exceptional service and support, from product training to technical assistance and after-sales service.

Intega Healthcare

Intega is a pharmaceutical and healthcare specialist committed to providing access to affordable healthcare, proven quality medicines, and first-class treatments throughout South East Asia. We have a proven track record in implementing business strategies for large multi-national organisations in the emerging South East Asian markets and are able to deliver market entry and strong growth for healthcare companies that are looking to develop a transparent, trusting, long-term partnership.

We provide:

Strong & relevant product branding, endorsed by the Intega brand name
Creative & targeted promotional material
Dynamic sales teams, experienced in the respective local markets
Customer knowledge and established relationships
Proven & dependable logistics

Junnimed Services Pte Ltd

At Junnimed Services Pte Ltd, we are committed to revolutionising the healthcare industry by providing state-of-the-art medical equipment and professional solutions that cater to the diverse needs of our clients. Our mission is to ensure that every healthcare provider, from hospitals to clinics, has access to cutting-edge technology at competitive prices, enabling them to deliver the highest standard of patient care. We recognise that quality healthcare is not just about advanced equipment but also about accessibility, affordability, and reliability.

Driven by a vision to be a trusted leader in medical technology, we strive to bring in innovative solutions that enhance the efficiency and effectiveness of healthcare services. We are dedicated to supplying medical technology that meets the highest standards of reliability and quality, ensuring that every product we provide contributes to better patient outcomes. Our goal is to bridge the gap between technological advancements and healthcare accessibility, making modern medical solutions available to institutions of all sizes without compromising affordability.

Lowenstein Medical

The willingness to provide service, a pronounced customer proximity, and innovative strength in the development of new medical technologies are the decisive factors that have made Lowenstein Medical a leading medical technology company.

Lowenstein Medical is considered a pioneer and market leader for medical products in the hospital, homecare, and diagnostic sectors. Innovative technology, ergonomic design, and creative user interfaces characterise high-end systems and enable optimal support for the user in every situation. The success of “Made in Germany” products is based on excellent ideas, many years of experience, foresight, and innovation.

Since Reinhard Lowenstein joined the company in 1986, their core competence has been in the field of neonatology. Today’s core competencies were developed from our expertise and knowledge of neonatology.

In the Hospital division, Lowenstein Medical offers ventilation solutions specifically for newborns, anesthesia equipment, and intensive care ventilators for adults as well as children. In addition, the Homecare division was developed, which equips patients with supplies who require medical aids in their home environment. These aids are mainly used for the treatment of lung diseases or sleep-related respiratory disorders. The third and final division is Diagnostics, which aims to develop and market innovative products for the diagnosis of sleep-related breathing disorders.

Lowenstein Medical is there for you, from the initial diagnosis to hospitalisation to surgery or homecare. Our focus is on service – in all areas.

You can find more information about the company and its products at: www.loewensteinmedical.com

Sandoz

Sandoz is the leading global provider of off-patent medicines. These generic and biosimilar medicines are more affordable than reference medicines. With a comprehensive portfolio of ~1,500 products covering most major therapeutic areas and available in 100+ countries, we make a real difference for patients and healthcare systems worldwide. We provide more than 800 million patient treatments per year, generating more than USD 18 billion in direct savings in the US and Europe alone, improving healthcare by freeing up resources and resulting in a total social impact estimated at around USD 400 billion per year worldwide.

In addition to leadership in driving access to high quality, cutting-edge medicines, we have an impressive history of medical innovation, including some truly transformative treatments. Today, we’re continuing to build on that deep scientific heritage with a strong pipeline of important off-patent medicines ranging from complex generics to biosimilars and beyond. Our purpose of pioneering access for patients drives everything we do, from ensuring the sustainability of critical antibiotics to democratising access to powerful biologic medicines.

For more information, please visit www.sandoz.com